Pfizer’s ABRYSVO gains EU approval for RSV prevention in adults 18-59 EP News Bureau Apr 2, 2025 European Commission amends marketing authorisation for Pfizer’s ABRYSVO vaccine, extending RSV protection to adults 18 and older…
US FDA approves ABRYSVO, Pfizer’s maternal RSV vaccine for infants EP News Bureau Aug 22, 2023 First and only US approval of a maternal vaccine to help protect infants at birth through six months of life from lower…
Pfizer and GSK to battle for share of new RSV vaccine market: GlobalData EP News Bureau Jun 13, 2023 Pfizer's RSV vaccine, Abrysvo, approved by the FDA just weeks after Arexvy, is likely to show GSK significant competition
